Differences in colorectal carcinoma stage and survival by race and ethnicity

✍ Scribed by Chloe Chien; Libby M. Morimoto; Jamie Tom; Christopher I. Li

• Publisher: John Wiley and Sons
• Year: 2005
• Tongue: English
• Weight: 104 KB
• Volume: 104
• Category: Article
• ISSN: 0008-543X
• DOI: 10.1002/cncr.21204

✦ Synopsis

Abstract

BACKGROUND

In the United States, blacks with colorectal carcinoma (CRC) presented with more advanced‐stage disease and had higher mortality rates compared with non‐Hispanic whites. Data regarding other races/ethnicities were limited, especially for Asian/Pacific Islander and Hispanic white subgroups.

METHODS

Using data from 11 population‐based cancer registries that participate in the Surveillance, Epidemiology and End Results program, the authors evaluated the relation among 18 different races/ethnicities and disease stage and mortality rates among 154,103 subjects diagnosed with CRC from 1988 to 2000.

RESULTS

Compared with non‐Hispanic whites, blacks, American Indians, Chinese, Filipinos, Koreans, Hawaiians, Mexicans, South/Central Americans, and Puerto Ricans were 10–60% more likely to be diagnosed with Stage III or IV CRC. Alternatively, Japanese had a 20% lower risk of advanced‐stage CRC. With respect to mortality rates, blacks, American Indians, Hawaiians, and Mexicans had a 20–30% greater risk of mortality, whereas Chinese, Japanese, and Indians/Pakistanis had a 10–40 % lower risk.

CONCLUSIONS

The authors observed numerous racial/ethnic disparities in the risks of advanced‐stage cancer and mortality among patients with CRC, and there was considerable variation in these risks across Asian/Pacific Islander and Hispanic white subgroups. Although the etiology of these disparities was multifactorial, developing screening and treatment programs that target racial/ethnic populations with elevated risks of poor CRC outcomes may be an important means of reducing these disparities. Cancer 2005. © 2005 American Cancer Society.